Rafael Malgor
Concepts (342)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 26 | 2026 | 395 | 6.950 |
Why?
| | Vascular Surgical Procedures | 22 | 2026 | 347 | 4.920 |
Why?
| | Blood Vessel Prosthesis Implantation | 16 | 2025 | 229 | 3.450 |
Why?
| | Venous Thrombosis | 11 | 2026 | 199 | 3.080 |
Why?
| | Aortic Aneurysm, Abdominal | 10 | 2025 | 168 | 2.780 |
Why?
| | Angioplasty, Balloon | 6 | 2023 | 97 | 2.770 |
Why?
| | Stents | 15 | 2024 | 570 | 2.750 |
Why?
| | Vascular System Injuries | 10 | 2026 | 83 | 2.360 |
Why?
| | Varicose Veins | 6 | 2024 | 16 | 2.250 |
Why?
| | Upper Extremity | 4 | 2026 | 114 | 2.200 |
Why?
| | Vena Cava, Inferior | 7 | 2026 | 83 | 2.140 |
Why?
| | Surgeons | 7 | 2025 | 342 | 1.950 |
Why?
| | Wounds, Nonpenetrating | 10 | 2026 | 324 | 1.920 |
Why?
| | Carotid Stenosis | 5 | 2024 | 107 | 1.910 |
Why?
| | Venous Insufficiency | 6 | 2024 | 12 | 1.890 |
Why?
| | Vena Cava Filters | 5 | 2024 | 69 | 1.830 |
Why?
| | Aorta, Thoracic | 8 | 2026 | 288 | 1.780 |
Why?
| | Pulmonary Embolism | 5 | 2024 | 246 | 1.760 |
Why?
| | Treatment Outcome | 51 | 2026 | 11947 | 1.720 |
Why?
| | Femoral Artery | 4 | 2023 | 190 | 1.690 |
Why?
| | Veins | 5 | 2017 | 69 | 1.620 |
Why?
| | Aortic Aneurysm | 3 | 2022 | 70 | 1.610 |
Why?
| | Thoracic Injuries | 6 | 2026 | 72 | 1.560 |
Why?
| | Peripheral Arterial Disease | 6 | 2023 | 510 | 1.550 |
Why?
| | Blood Vessel Prosthesis | 10 | 2024 | 141 | 1.490 |
Why?
| | Popliteal Artery | 3 | 2023 | 62 | 1.470 |
Why?
| | Ultrasonography, Doppler, Duplex | 9 | 2017 | 40 | 1.430 |
Why?
| | Ischemia | 7 | 2021 | 424 | 1.390 |
Why?
| | Anticoagulants | 8 | 2026 | 751 | 1.380 |
Why?
| | Intermittent Claudication | 3 | 2021 | 122 | 1.370 |
Why?
| | Venous Thromboembolism | 6 | 2022 | 330 | 1.350 |
Why?
| | Laser Therapy | 4 | 2022 | 146 | 1.210 |
Why?
| | Saphenous Vein | 5 | 2022 | 37 | 1.150 |
Why?
| | Vascular Patency | 11 | 2026 | 122 | 1.140 |
Why?
| | Endarterectomy, Carotid | 2 | 2024 | 64 | 1.080 |
Why?
| | Aorta, Abdominal | 2 | 2025 | 52 | 1.040 |
Why?
| | Lower Extremity | 6 | 2025 | 452 | 1.030 |
Why?
| | Upper Extremity Deep Vein Thrombosis | 1 | 2026 | 3 | 0.950 |
Why?
| | Catheter Ablation | 3 | 2022 | 360 | 0.920 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2025 | 17 | 0.920 |
Why?
| | Risk Factors | 26 | 2026 | 11017 | 0.900 |
Why?
| | Doxycycline | 1 | 2025 | 62 | 0.900 |
Why?
| | Thrombectomy | 1 | 2026 | 79 | 0.890 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2025 | 133 | 0.870 |
Why?
| | Arteriovenous Shunt, Surgical | 2 | 2017 | 20 | 0.870 |
Why?
| | Humans | 98 | 2026 | 147293 | 0.870 |
Why?
| | Atherectomy | 2 | 2023 | 37 | 0.860 |
Why?
| | Iliac Aneurysm | 2 | 2022 | 19 | 0.860 |
Why?
| | Prosthesis Design | 10 | 2024 | 363 | 0.850 |
Why?
| | Time Factors | 24 | 2026 | 7173 | 0.830 |
Why?
| | Fibrinolytic Agents | 3 | 2020 | 303 | 0.830 |
Why?
| | Inflammation Mediators | 2 | 2025 | 507 | 0.810 |
Why?
| | Health Care Costs | 2 | 2025 | 428 | 0.790 |
Why?
| | Cranial Nerve Injuries | 1 | 2023 | 5 | 0.770 |
Why?
| | Carotid Body Tumor | 1 | 2023 | 5 | 0.760 |
Why?
| | Aged | 36 | 2026 | 26514 | 0.760 |
Why?
| | Mesenteric Vascular Occlusion | 3 | 2011 | 5 | 0.750 |
Why?
| | Aged, 80 and over | 18 | 2024 | 8430 | 0.740 |
Why?
| | Embolic Protection Devices | 1 | 2022 | 12 | 0.740 |
Why?
| | Vascular Diseases | 3 | 2015 | 252 | 0.720 |
Why?
| | Aortic Aneurysm, Thoracic | 3 | 2024 | 138 | 0.710 |
Why?
| | Anti-Inflammatory Agents | 1 | 2025 | 481 | 0.700 |
Why?
| | Intestinal Perforation | 2 | 2012 | 46 | 0.700 |
Why?
| | Duodenum | 2 | 2012 | 80 | 0.690 |
Why?
| | Practice Patterns, Physicians' | 4 | 2020 | 1379 | 0.680 |
Why?
| | Coated Materials, Biocompatible | 1 | 2021 | 65 | 0.660 |
Why?
| | Retrospective Studies | 23 | 2026 | 17560 | 0.660 |
Why?
| | Vascular Calcification | 2 | 2020 | 110 | 0.650 |
Why?
| | Renal Dialysis | 2 | 2017 | 467 | 0.650 |
Why?
| | Angioplasty | 3 | 2012 | 50 | 0.640 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2021 | 499 | 0.630 |
Why?
| | Male | 48 | 2026 | 73950 | 0.620 |
Why?
| | Middle Aged | 35 | 2026 | 36821 | 0.620 |
Why?
| | Lithotripsy | 1 | 2020 | 49 | 0.610 |
Why?
| | Female | 54 | 2026 | 80076 | 0.610 |
Why?
| | Leg | 3 | 2021 | 243 | 0.600 |
Why?
| | Plaque, Atherosclerotic | 1 | 2020 | 61 | 0.600 |
Why?
| | Benchmarking | 1 | 2021 | 194 | 0.590 |
Why?
| | Aorta | 2 | 2012 | 443 | 0.590 |
Why?
| | Risk Adjustment | 1 | 2019 | 85 | 0.580 |
Why?
| | Watchful Waiting | 1 | 2019 | 90 | 0.570 |
Why?
| | Postoperative Complications | 12 | 2025 | 3022 | 0.530 |
Why?
| | Iliac Artery | 2 | 2022 | 55 | 0.520 |
Why?
| | Atherosclerosis | 1 | 2021 | 411 | 0.510 |
Why?
| | Prosthesis Failure | 3 | 2019 | 127 | 0.510 |
Why?
| | Surgical Stapling | 1 | 2017 | 15 | 0.500 |
Why?
| | Vascular Malformations | 2 | 2015 | 53 | 0.500 |
Why?
| | Thoracoscopy | 1 | 2017 | 60 | 0.500 |
Why?
| | Aneurysm | 1 | 2017 | 37 | 0.490 |
Why?
| | Sclerotherapy | 3 | 2024 | 19 | 0.480 |
Why?
| | Medicare | 1 | 2022 | 915 | 0.460 |
Why?
| | Hand | 1 | 2017 | 157 | 0.450 |
Why?
| | Brachial Artery | 1 | 2017 | 209 | 0.450 |
Why?
| | Pneumonectomy | 1 | 2017 | 167 | 0.440 |
Why?
| | Peripheral Vascular Diseases | 2 | 2013 | 105 | 0.440 |
Why?
| | Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 5 | 0.440 |
Why?
| | Registries | 7 | 2025 | 2434 | 0.420 |
Why?
| | Risk Assessment | 10 | 2025 | 3784 | 0.420 |
Why?
| | Subclavian Artery | 1 | 2014 | 28 | 0.420 |
Why?
| | Perception | 1 | 2017 | 378 | 0.410 |
Why?
| | Catheterization | 2 | 2012 | 184 | 0.410 |
Why?
| | Tissue and Organ Harvesting | 1 | 2014 | 78 | 0.410 |
Why?
| | Arterial Occlusive Diseases | 1 | 2014 | 90 | 0.400 |
Why?
| | Infarction | 1 | 2013 | 9 | 0.400 |
Why?
| | Endarterectomy | 2 | 2012 | 5 | 0.390 |
Why?
| | Cardiovascular Agents | 1 | 2015 | 166 | 0.390 |
Why?
| | Adult | 26 | 2026 | 41405 | 0.390 |
Why?
| | Renal Artery | 1 | 2013 | 43 | 0.390 |
Why?
| | Brachiocephalic Trunk | 1 | 2012 | 11 | 0.380 |
Why?
| | Intraoperative Complications | 1 | 2014 | 158 | 0.380 |
Why?
| | Catheter Obstruction | 1 | 2012 | 4 | 0.380 |
Why?
| | Phlebography | 5 | 2021 | 41 | 0.370 |
Why?
| | Device Removal | 4 | 2024 | 149 | 0.370 |
Why?
| | Vascular Access Devices | 1 | 2012 | 30 | 0.360 |
Why?
| | Mechanical Thrombolysis | 1 | 2012 | 5 | 0.360 |
Why?
| | Ureteral Diseases | 1 | 2012 | 4 | 0.360 |
Why?
| | Urinary Fistula | 1 | 2012 | 12 | 0.350 |
Why?
| | Catheters, Indwelling | 1 | 2012 | 96 | 0.350 |
Why?
| | Fibrin Tissue Adhesive | 1 | 2012 | 20 | 0.350 |
Why?
| | Vascular Fistula | 1 | 2012 | 22 | 0.350 |
Why?
| | Health Services Accessibility | 1 | 2020 | 1121 | 0.350 |
Why?
| | Endoscopy | 1 | 2014 | 322 | 0.350 |
Why?
| | Aneurysm, False | 1 | 2012 | 46 | 0.340 |
Why?
| | Time-to-Treatment | 3 | 2026 | 258 | 0.340 |
Why?
| | Lung Neoplasms | 2 | 2017 | 2679 | 0.340 |
Why?
| | Elective Surgical Procedures | 2 | 2024 | 203 | 0.320 |
Why?
| | Thrombin | 1 | 2012 | 174 | 0.320 |
Why?
| | Catheterization, Central Venous | 1 | 2012 | 124 | 0.320 |
Why?
| | Thrombolytic Therapy | 1 | 2012 | 165 | 0.320 |
Why?
| | Surgical Wound Infection | 2 | 2024 | 334 | 0.310 |
Why?
| | Foreign-Body Migration | 1 | 2010 | 33 | 0.310 |
Why?
| | Celiac Artery | 2 | 2025 | 20 | 0.310 |
Why?
| | Exercise Therapy | 1 | 2015 | 489 | 0.300 |
Why?
| | Length of Stay | 4 | 2024 | 1371 | 0.300 |
Why?
| | Tomography, X-Ray Computed | 7 | 2014 | 2791 | 0.300 |
Why?
| | Limb Salvage | 4 | 2025 | 75 | 0.290 |
Why?
| | Hospital Mortality | 4 | 2024 | 1043 | 0.290 |
Why?
| | New York | 3 | 2014 | 128 | 0.280 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2017 | 1431 | 0.280 |
Why?
| | Evidence-Based Medicine | 5 | 2026 | 742 | 0.280 |
Why?
| | Aortography | 3 | 2014 | 53 | 0.280 |
Why?
| | Injury Severity Score | 4 | 2026 | 602 | 0.270 |
Why?
| | Cost-Benefit Analysis | 2 | 2025 | 653 | 0.270 |
Why?
| | Regional Blood Flow | 3 | 2017 | 514 | 0.270 |
Why?
| | Constriction, Pathologic | 3 | 2013 | 252 | 0.250 |
Why?
| | Sternum | 2 | 2024 | 27 | 0.250 |
Why?
| | Health Care Surveys | 2 | 2020 | 538 | 0.250 |
Why?
| | Reoperation | 5 | 2019 | 644 | 0.250 |
Why?
| | Sternotomy | 2 | 2024 | 25 | 0.250 |
Why?
| | Endoleak | 2 | 2019 | 17 | 0.240 |
Why?
| | Stroke | 2 | 2026 | 1287 | 0.240 |
Why?
| | Cerebrovascular Trauma | 1 | 2026 | 23 | 0.240 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2026 | 28 | 0.240 |
Why?
| | Internship and Residency | 3 | 2021 | 1279 | 0.230 |
Why?
| | Aortic Rupture | 2 | 2020 | 28 | 0.230 |
Why?
| | Median Arcuate Ligament Syndrome | 1 | 2025 | 8 | 0.230 |
Why?
| | Ulcer | 1 | 2025 | 37 | 0.230 |
Why?
| | Kidney | 1 | 2013 | 1511 | 0.220 |
Why?
| | Hematoma | 1 | 2025 | 63 | 0.220 |
Why?
| | Sclerosing Solutions | 1 | 2024 | 10 | 0.220 |
Why?
| | Databases, Factual | 4 | 2026 | 1504 | 0.220 |
Why?
| | Kaplan-Meier Estimate | 3 | 2012 | 975 | 0.220 |
Why?
| | Implant Capsular Contracture | 1 | 2024 | 5 | 0.210 |
Why?
| | Young Adult | 9 | 2025 | 14437 | 0.210 |
Why?
| | Renal Nutcracker Syndrome | 1 | 2024 | 8 | 0.210 |
Why?
| | Hematuria | 1 | 2024 | 11 | 0.210 |
Why?
| | Breast Implantation | 1 | 2024 | 21 | 0.210 |
Why?
| | Breast Implants | 1 | 2024 | 32 | 0.210 |
Why?
| | Aortic Diseases | 1 | 2025 | 126 | 0.200 |
Why?
| | Urologic Diseases | 1 | 2024 | 42 | 0.200 |
Why?
| | Stockings, Compression | 2 | 2015 | 5 | 0.200 |
Why?
| | Carcinoma, Renal Cell | 1 | 2026 | 233 | 0.200 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2023 | 29 | 0.200 |
Why?
| | Predictive Value of Tests | 5 | 2024 | 2133 | 0.200 |
Why?
| | Sarcoma | 1 | 2026 | 210 | 0.200 |
Why?
| | Accidents, Traffic | 2 | 2015 | 195 | 0.190 |
Why?
| | Incidence | 5 | 2025 | 2954 | 0.190 |
Why?
| | Down-Regulation | 1 | 2025 | 618 | 0.190 |
Why?
| | C-Reactive Protein | 1 | 2025 | 430 | 0.190 |
Why?
| | Patient Selection | 3 | 2026 | 746 | 0.190 |
Why?
| | Neoplasms | 3 | 2025 | 2946 | 0.190 |
Why?
| | Intracranial Embolism | 1 | 2022 | 34 | 0.190 |
Why?
| | Surgical Flaps | 1 | 2024 | 142 | 0.180 |
Why?
| | Robotic Surgical Procedures | 1 | 2025 | 207 | 0.180 |
Why?
| | Health Status Disparities | 1 | 2025 | 324 | 0.180 |
Why?
| | Lymphedema | 1 | 2022 | 22 | 0.180 |
Why?
| | Angiography | 2 | 2013 | 209 | 0.180 |
Why?
| | Acute Disease | 4 | 2025 | 1049 | 0.180 |
Why?
| | Multiple Trauma | 2 | 2021 | 121 | 0.180 |
Why?
| | Morbidity | 1 | 2023 | 323 | 0.170 |
Why?
| | Administration, Oral | 2 | 2021 | 874 | 0.170 |
Why?
| | Off-Label Use | 1 | 2022 | 51 | 0.170 |
Why?
| | Surveys and Questionnaires | 7 | 2022 | 6164 | 0.170 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1776 | 0.170 |
Why?
| | Varicose Ulcer | 1 | 2021 | 5 | 0.170 |
Why?
| | Kidney Neoplasms | 1 | 2026 | 421 | 0.170 |
Why?
| | Follow-Up Studies | 4 | 2021 | 5476 | 0.170 |
Why?
| | Mesenteric Arteries | 2 | 2011 | 17 | 0.170 |
Why?
| | Neurosurgery | 1 | 2021 | 41 | 0.170 |
Why?
| | Prognosis | 4 | 2015 | 4383 | 0.170 |
Why?
| | Iliac Vein | 1 | 2021 | 15 | 0.160 |
Why?
| | Abdominal Pain | 2 | 2012 | 149 | 0.160 |
Why?
| | Catheters | 1 | 2021 | 74 | 0.160 |
Why?
| | Prospective Studies | 6 | 2021 | 8164 | 0.160 |
Why?
| | Global Health | 2 | 2020 | 406 | 0.160 |
Why?
| | Brazil | 1 | 2020 | 179 | 0.160 |
Why?
| | Efficiency | 1 | 2021 | 103 | 0.160 |
Why?
| | Ultrasonography, Interventional | 2 | 2012 | 166 | 0.150 |
Why?
| | Puerperal Disorders | 1 | 2020 | 36 | 0.150 |
Why?
| | Pandemics | 4 | 2020 | 1720 | 0.150 |
Why?
| | Certification | 1 | 2021 | 119 | 0.150 |
Why?
| | Arteriovenous Fistula | 1 | 2020 | 38 | 0.150 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2020 | 85 | 0.150 |
Why?
| | Patient Care Team | 1 | 2025 | 712 | 0.150 |
Why?
| | Chronic Disease | 5 | 2024 | 1844 | 0.150 |
Why?
| | Catheterization, Peripheral | 1 | 2021 | 120 | 0.150 |
Why?
| | Patient Acuity | 1 | 2019 | 48 | 0.150 |
Why?
| | United States | 9 | 2025 | 16313 | 0.150 |
Why?
| | Recurrence | 3 | 2012 | 1151 | 0.150 |
Why?
| | Education, Medical, Graduate | 2 | 2021 | 568 | 0.140 |
Why?
| | Cardiology | 1 | 2022 | 364 | 0.140 |
Why?
| | General Surgery | 1 | 2021 | 207 | 0.140 |
Why?
| | Delphi Technique | 3 | 2025 | 347 | 0.130 |
Why?
| | Clinical Decision-Making | 2 | 2021 | 367 | 0.130 |
Why?
| | Educational Measurement | 1 | 2021 | 332 | 0.130 |
Why?
| | Disease Progression | 1 | 2025 | 2890 | 0.130 |
Why?
| | Disease Management | 1 | 2021 | 654 | 0.130 |
Why?
| | Ligation | 1 | 2017 | 91 | 0.130 |
Why?
| | Military Personnel | 1 | 2025 | 749 | 0.120 |
Why?
| | Consensus | 3 | 2026 | 476 | 0.120 |
Why?
| | Thrombosis | 1 | 2020 | 401 | 0.120 |
Why?
| | Postoperative Hemorrhage | 1 | 2017 | 106 | 0.120 |
Why?
| | Clinical Competence | 3 | 2021 | 1260 | 0.120 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 462 | 0.110 |
Why?
| | Motorcycles | 1 | 2014 | 7 | 0.110 |
Why?
| | Ankle Brachial Index | 1 | 2015 | 41 | 0.110 |
Why?
| | Pedestrians | 1 | 2014 | 9 | 0.110 |
Why?
| | Adaptation, Psychological | 1 | 2020 | 736 | 0.110 |
Why?
| | Obesity, Morbid | 1 | 2019 | 298 | 0.110 |
Why?
| | Cross-Sectional Studies | 3 | 2020 | 6011 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2973 | 0.100 |
Why?
| | Biomarkers | 1 | 2025 | 4351 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.100 |
Why?
| | Minnesota | 1 | 2013 | 168 | 0.090 |
Why?
| | Exercise Tolerance | 1 | 2015 | 289 | 0.090 |
Why?
| | Ovary | 1 | 2014 | 236 | 0.090 |
Why?
| | Duodenoscopy | 1 | 2012 | 8 | 0.090 |
Why?
| | Gastroscopy | 1 | 2012 | 18 | 0.090 |
Why?
| | Matrix Metalloproteinases | 1 | 2013 | 95 | 0.090 |
Why?
| | MEDLINE | 1 | 2012 | 20 | 0.090 |
Why?
| | Injections, Intralesional | 1 | 2012 | 35 | 0.090 |
Why?
| | Cystoscopy | 1 | 2012 | 21 | 0.090 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2012 | 37 | 0.090 |
Why?
| | Debridement | 1 | 2012 | 85 | 0.090 |
Why?
| | Stress, Psychological | 1 | 2020 | 1174 | 0.090 |
Why?
| | Combined Modality Therapy | 1 | 2015 | 1281 | 0.090 |
Why?
| | Adolescent | 5 | 2025 | 22825 | 0.090 |
Why?
| | Carotid Artery, Common | 1 | 2011 | 32 | 0.090 |
Why?
| | Hospitalization | 1 | 2022 | 2496 | 0.080 |
Why?
| | Echinococcosis | 1 | 2011 | 9 | 0.080 |
Why?
| | Fibrinolysis | 1 | 2013 | 164 | 0.080 |
Why?
| | Pilot Projects | 1 | 2017 | 1912 | 0.080 |
Why?
| | Mesenteric Ischemia | 1 | 2010 | 2 | 0.080 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 430 | 0.080 |
Why?
| | Warfarin | 1 | 2022 | 179 | 0.080 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2011 | 139 | 0.080 |
Why?
| | Recovery of Function | 1 | 2015 | 724 | 0.080 |
Why?
| | Coronary Artery Bypass | 1 | 2012 | 269 | 0.080 |
Why?
| | Embolization, Therapeutic | 1 | 2012 | 246 | 0.080 |
Why?
| | Linear Models | 1 | 2012 | 852 | 0.080 |
Why?
| | Walking | 1 | 2015 | 549 | 0.080 |
Why?
| | Glomerular Filtration Rate | 1 | 2013 | 765 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 528 | 0.070 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 170 | 0.070 |
Why?
| | Dog Diseases | 1 | 2011 | 141 | 0.070 |
Why?
| | Secondary Prevention | 1 | 2011 | 253 | 0.070 |
Why?
| | Mesentery | 1 | 2009 | 44 | 0.070 |
Why?
| | Radiography, Interventional | 1 | 2010 | 128 | 0.070 |
Why?
| | Animals | 3 | 2025 | 38410 | 0.070 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1550 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1220 | 0.070 |
Why?
| | Recombinant Proteins | 1 | 2012 | 1371 | 0.070 |
Why?
| | Logistic Models | 1 | 2012 | 2142 | 0.060 |
Why?
| | Child | 3 | 2021 | 22979 | 0.060 |
Why?
| | Age Factors | 1 | 2014 | 3372 | 0.060 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1344 | 0.060 |
Why?
| | Survival Rate | 1 | 2012 | 2110 | 0.060 |
Why?
| | Hemorrhage | 1 | 2022 | 832 | 0.060 |
Why?
| | Cardiac Surgical Procedures | 1 | 2012 | 616 | 0.060 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 754 | 0.060 |
Why?
| | Hemodynamics | 2 | 2021 | 1127 | 0.060 |
Why?
| | United States Department of Defense | 1 | 2025 | 26 | 0.050 |
Why?
| | Silicone Gels | 1 | 2024 | 5 | 0.050 |
Why?
| | Renal Veins | 1 | 2024 | 18 | 0.050 |
Why?
| | Operative Time | 1 | 2025 | 195 | 0.050 |
Why?
| | Pectoralis Muscles | 1 | 2024 | 18 | 0.050 |
Why?
| | Surgical Wound Dehiscence | 1 | 2023 | 22 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2025 | 512 | 0.050 |
Why?
| | Quality of Life | 1 | 2015 | 3246 | 0.040 |
Why?
| | Research Design | 1 | 2008 | 1157 | 0.040 |
Why?
| | Mammaplasty | 1 | 2024 | 148 | 0.040 |
Why?
| | Test Taking Skills | 1 | 2021 | 5 | 0.040 |
Why?
| | Plastics | 1 | 2021 | 50 | 0.040 |
Why?
| | Verbal Behavior | 1 | 2021 | 42 | 0.040 |
Why?
| | Cohort Studies | 1 | 2012 | 6099 | 0.040 |
Why?
| | Administration, Topical | 1 | 2021 | 156 | 0.040 |
Why?
| | Wound Healing | 1 | 2023 | 361 | 0.040 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 58 | 0.040 |
Why?
| | Specialties, Surgical | 1 | 2020 | 84 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2136 | 0.040 |
Why?
| | Signal Transduction | 1 | 2013 | 5272 | 0.040 |
Why?
| | Factor Xa Inhibitors | 1 | 2021 | 194 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2021 | 428 | 0.040 |
Why?
| | Educational Status | 1 | 2021 | 475 | 0.040 |
Why?
| | Workload | 1 | 2020 | 172 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2020 | 537 | 0.030 |
Why?
| | Treatment Failure | 1 | 2019 | 360 | 0.030 |
Why?
| | Salvage Therapy | 1 | 2019 | 166 | 0.030 |
Why?
| | Hot Temperature | 1 | 2020 | 396 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 1147 | 0.030 |
Why?
| | Ankle | 1 | 2015 | 69 | 0.030 |
Why?
| | Pressure | 1 | 2015 | 228 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2015 | 104 | 0.030 |
Why?
| | Materials Testing | 1 | 2015 | 346 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1672 | 0.030 |
Why?
| | Sclerosis | 1 | 2013 | 11 | 0.020 |
Why?
| | Wound Infection | 1 | 2012 | 60 | 0.020 |
Why?
| | Antigens, Helminth | 1 | 2011 | 16 | 0.020 |
Why?
| | Sheep Diseases | 1 | 2011 | 9 | 0.020 |
Why?
| | Anthelmintics | 1 | 2011 | 12 | 0.020 |
Why?
| | Italy | 1 | 2011 | 118 | 0.020 |
Why?
| | Rabbits | 1 | 2011 | 654 | 0.020 |
Why?
| | Spinal Cord Ischemia | 1 | 2010 | 60 | 0.020 |
Why?
| | Dogs | 1 | 2011 | 518 | 0.020 |
Why?
| | Magnetic Resonance Angiography | 1 | 2011 | 251 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 849 | 0.020 |
Why?
| | Sheep | 1 | 2011 | 879 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 652 | 0.020 |
Why?
| | Feces | 1 | 2011 | 500 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 7274 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 2889 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 2010 | 600 | 0.010 |
Why?
|
|
Malgor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|